The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development

Dipender Gill, Loukas Zagkos, Rubinder Gill, Thomas Benzing, Jens Jordan, Andreas L. Birkenfeld, Stephen Burgess, Grit Zahn
doi: https://doi.org/10.1101/2023.08.29.23294760
Back to top
Posted August 29, 2023.
Download PDF

Supplementary Material

Data/Code
Email
The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development
Dipender Gill, Loukas Zagkos, Rubinder Gill, Thomas Benzing, Jens Jordan, Andreas L. Birkenfeld, Stephen Burgess, Grit Zahn
medRxiv 2023.08.29.23294760; doi: https://doi.org/10.1101/2023.08.29.23294760
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area